Press Releases

All Releases
View Summary Ironwood Pharmaceuticals Announces Upcoming Presentation at Credit Suisse 2010 Healthcare Conference
Nov 5, 2010
PDF 13.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2010 Investor Update
Nov 4, 2010
PDF 27.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
Nov 1, 2010
PDF 13.4 KB Add to Briefcase
View Summary Almirall and Ironwood Announce Positive Results from the Second Phase 3 Trial of Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Nov 1, 2010
PDF 26.2 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Second Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation
Nov 1, 2010
PDF 24.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Conference Call to Discuss Positive Linaclotide Phase 3 IBS-C Results
Sep 13, 2010
PDF 13.4 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Phase 3 Trial in Patients with Irritable Bowel Syndrome with Constipation
Sep 13, 2010
PDF 23.7 KB Add to Briefcase
View Summary Almirall and Ironwood Announce Positive Results from a Phase 3 Trial with Linaclotide in Patients with Irritable Bowel Syndrome with Constipation
Sep 13, 2010
PDF 23.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Upcoming Presentation at Morgan Stanley Global Healthcare Conference
Sep 9, 2010
PDF 13.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Second Quarter 2010 Investor Update
Aug 5, 2010
PDF 22.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Second Quarter 2010 Investor Update Call
Aug 2, 2010
PDF 13.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010
Jul 28, 2010
PDF 13.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Participation in J.P. Morgan Biotech CEO/CFO Conference Call
May 26, 2010
PDF 12.8 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2010 Investor Update
May 11, 2010
PDF 23.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces First Quarter 2010 Investor Update Call and Upcoming Presentation at Bank of America Merrill Lynch 2010 Health Care Conference
May 7, 2010
PDF 14.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Annual Report on Form 10-K
Mar 30, 2010
PDF 13.2 KB Add to Briefcase
View Summary Underwriters Exercise Over-Allotment Option for Ironwood Pharmaceuticals' Initial Public Offering
Feb 16, 2010
PDF 16.2 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Registration Statement for Initial Public Offering
Nov 20, 2009
PDF 12.6 KB Add to Briefcase
View Summary Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
Nov 10, 2009
PDF 14.1 KB Add to Briefcase
View Summary Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials In Patients with Chronic Constipation
Nov 2, 2009
PDF 20.7 KB Add to Briefcase
Showing 221-240 of 255 Page: 1 ... 8 9 10 11 12 13  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.